This is a preview of subscription content, log in via an institution to check access.
References
Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431–448.
Dalley CD, Neat MJ, Foot NJ, Burridge M, Byrne L, Amess JA et al. Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia. Hematol J 2002; 3: 290–298.
Frohling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Dohner H et al. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 2002; 20: 2480–2485.
Paulsson K, Heidenblad M, Strombeck B, Staaf J, Jonsson G, Borg A et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006; 20: 840–846.
Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Frohling S et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006; 24: 3887–3894.
Tyybakinoja A, Saarinen-Pihkala U, Elonen E, Knuutila S . Amplified, lost, and fused genes in 11q23–25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer 2006; 45: 257–264.
Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM et al. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525–1533.
Storlazzi CT, Fioretos T, Surace C, Lonoce A, Mastrorilli A, Strombeck B et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 2006; 15: 933–942.
Acknowledgements
This work was supported by grants from the Foundation for the Finnish Cancer Institute and Helsinki University Central Hospital research funds.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Tyybäkinoja, A., Elonen, E., Piippo, K. et al. Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia 21, 571–574 (2007). https://doi.org/10.1038/sj.leu.2404543
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404543
- Springer Nature Limited
This article is cited by
-
Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results
Molecular Cytogenetics (2014)
-
DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype
Cellular Oncology (2013)
-
Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells
Molecular Cytogenetics (2011)
-
Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia
Molecular Cytogenetics (2011)
-
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
Leukemia (2010)